Enzon Pharmaceuticals (United States)

Recent papers from Enzon Pharmaceuticals (United States)

1. Fabrication and Characterization of Benzhydroxamic Acid-Loaded Dissolving Microneedles Using a 3D-Printing-Assisted Mold Fabrication ApproachMicromachines · 2026
2. Combined radiation and Listeria immunotherapy induces cytotoxic immunity that correlates with improved outcome in dogs with osteosarcomaMolecular Therapy Oncology · 2026
3. Development and validation of the IVENUS artificial intelligence model for automated CEAP classification of early-stage chronic venous disease using lower limb photographsJournal of Vascular Surgery Venous and Lymphatic Disorders · 2026
4. The paradigm shifts in cleaning validation: From arbitrary limits to science-based patient safety2025
5. Decoding iNOS Inhibition: A Computational Voyage of Tavaborole Toward Restoring Endothelial Homeostasis in Venous Leg UlcersPharmaceuticals · 2026
6. A Topical Agent Based on Recombinant Human Epidermal Growth Factor and Silver Sulfadiazine Accelerates the Healing of Venous (Chronic) Ulcers: A Prospective Comparative Non-Randomized Study ESKIZJournal of Venous Disorders · 2025
7. Secondary thigh telangiectasias after endovenous laser ablation of the great saphenous veinPhlebology The Journal of Venous Disease · 2025
8. Regulatory Considerations in Synthetic Peptide Characterization: Techniques and ComplianceSeparation Science Plus · 2025
9. Principles for Stereoselective Separation of Chiral Drug Compounds Enantiomers and Diastereomers in Pharmaceuticals and Biopharmaceuticals Using Liquid ChromatographyChirality · 2025
10. Superior bioavailability of EPA and DHA from a L-lysine salt formulation: a randomized, three-way crossover studyFood & Nutrition Research · 2024
11. Separation and quantification of organic‐related impurities of anti‐histamine drug hydroxyzine in pharmaceutical dosage forms using stability‐indicating high‐performance liquid chromatography, liquid chromatography‐mass spectrometry, and high‐resolution mass spectrometry techniquesSeparation Science Plus · 2024
12. Separation and simultaneous estimation of enantiomers and Diastereomers of muscarinic receptor antagonist Solifenacin using stability‐indicating Normal‐phase HPLC technique with chiral stationary phase amylose tris‐(3,5‐dimethylphenylcarbamate)Chirality · 2023
13. Separation and quantification of organic‐related impurities of beta‐adrenergic receptor blocking agent propranolol in pharmaceutical solid dosage forms: Impurity profiling using stability‐indicating HPLC methodSeparation Science Plus · 2023
14. Separation and quantitation of valacyclovir enantiomers using stability‐indicating chiral liquid chromatography method with a chiral stationary phase of amylose tris‐(3,5‐dimethylphenylcarbamate)Separation Science Plus · 2023
15. Separation and quantitative estimation of stereo‐selective enantiomers of montelukast in pharmaceutical drug substance and tablets dosage forms by using stability‐indicating normal phase‐HPLC methodChirality · 2023
16. Molecular docking, in-vitro anticancer evaluation and ADME profiling of 7-Oxo MidostaurinJournal of Molecular Structure · 2023
17. Hepatoprotective Potential of Aqueous Extract of Hibiscus rosasinensis and Butea monosperma against Fe-NTA induced Hepatotoxicity in RatsResearch Journal of Pharmacy and Technology · 2022
18. Role of duloxetine in neuropathic pain: A clinical impact, mechanism, challenges in formulation development to safety concernResearch Journal of Pharmacy and Technology · 2022
19. The Design and Rationale of a Phase 2b, Randomized, Double-Blinded, and Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Lomecel-B in Older Adults with FrailtyThe Journal of Frailty & Aging · 2021
20. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variablesDrug Development and Industrial Pharmacy · 2020